Funding for this research was provided by:
National Institute of Mental Health (R61MH111932, R56MH115409, R01MH120637)
Article History
Accepted: 28 November 2021
First Online: 8 March 2022
Declarations
:
: Research reported in this publication was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R61MH111932. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional funding for this article was provided by the Friedman Brain Institute and by the Ehrenkranz Laboratory for Human Resilience, both components of the Icahn School of Medicine at Mount Sinai and by the Gottesman Foundation. Additional research support was provided by the National Institute of Mental Health (R56MH115409, R01MH120637, Dr. Han).
: In the past 5 years, Dr. Murrough has provided consultation services and/or served on advisory boards for Allergan, Boehringer Ingelheim, Clexio Biosciences, FSV7, Global Medical Education (GME), Otsuka, and Sage Therapeutics. Dr. Murrough is named on a patent pending for neuropeptide Y as a treatment for mood and anxiety disorders and on a patent pending for the use of ezogabine and other KCNQ channel openers to treat depression and related conditions. The Icahn School of Medicine (employer of Dr. Murrough) is named on a patent and has entered into a licensing agreement and will receive payments related to the use of ketamine or esketamine for the treatment of depression. The Icahn School of Medicine is also named on a patent related to the use of ketamine for the treatment of post-traumatic stress disorder. Dr. Murrough is not named on these patents and will not receive any payments. Dr. Ming-Hu Han is named on a patent pending for the use of ezogabine (KCNQ channel opener) to treat depression and related conditions. Dr. Costi has provided consultation services for Guidepoint.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors devised the article. S.C. wrote the first draft of the article, M.H.H. drafted the figure, and all authors commented on drafts of the article.